Don't forget that there is a capital raising that is on offer at 25cents per share. I'd expect that this will peg the price until these are dealt with. Be patient.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
